Lifecore Biomedical (FRA:LDE) Inventories, Raw Materials & Components: €8.73 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LDE Lifecore Biomedical Inc FRA:LDE
58 GF Score
Price €3.98
GF Value €5.64
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Lifecore Biomedical Inventories, Raw Materials & Components?

Lifecore Biomedical FRA:LDE -2.45% 58 Inventories, Raw Materials & Components is €8.73 Mil as of Mar. 2026. GuruFocus rates FRA:LDE with a GF Score™ of 58/100 and a GF Value™ of €5.64 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Lifecore Biomedical's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €8.73 Mil.

Lifecore Biomedical's quarterly raw materials declined from Sep. 2025 (€10.48 Mil) to Dec. 2025 (€8.62 Mil) but then increased from Dec. 2025 (€8.62 Mil) to Mar. 2026 (€8.73 Mil).

Lifecore Biomedical's annual raw materials declined from May. 2023 (€16.32 Mil) to May. 2024 (€12.15 Mil) and declined from May. 2024 (€12.15 Mil) to May. 2025 (€9.02 Mil).

Lifecore Biomedical Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Inventories, Raw Materials & Components Chart

Lifecore Biomedical Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.70 14.65 16.32 12.15 9.02

Lifecore Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.59 9.02 10.48 8.62 8.73
FRA:LDE
58GF Score
Lifecore Biomedical Inc FRA:LDE
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecore Biomedical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €8.73 Mil mean?
Lifecore Biomedical (FRA:LDE) has a Inventories, Raw Materials & Components of €8.73 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Lifecore Biomedical and its competitors.
Is Lifecore Biomedical's Inventories, Raw Materials & Components too high?
Lifecore Biomedical's current Inventories, Raw Materials & Components is €8.73 Mil. Overall, Lifecore Biomedical has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's Inventories, Raw Materials & Components compare to ANIK and DERM?
Lifecore Biomedical's Inventories, Raw Materials & Components of €8.73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Lifecore Biomedical and its competitors. Lifecore Biomedical's current Inventories, Raw Materials & Components is €8.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (FRA:LDE) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.64, compared to a current price of €3.98 — trading 29.4% below its estimated fair value. The current Inventories, Raw Materials & Components is €8.73 Mil. Lifecore Biomedical's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Lifecore Biomedical (FRA:LDE), the current Inventories, Raw Materials & Components is €8.73 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (FRA:LDE) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of €3.98 is trading 29.4% below its estimated GF Value™ of €5.64. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for FRA:LDE:

  • Inventories, Raw Materials & Components: €8.73 Mil
  • GF Value™: €5.64 vs. price of €3.98 (29.4% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the FRA:LDE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifecore Biomedical Business Description

Other Exchanges LFCR:USA
Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
58GF Score

Get the complete analysis for FRA:LDE

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.98
Price
€5.64
GF Value